Eileen Moritz
Impact in
-
- Sphingolipid Metabolism and Signaling
- Bone Metabolism and Diseases
- Lipid Membrane Structure and Behavior
- Inflammasome and immune disorders
Papers in
-
- Sphingolipid Metabolism and Signaling 13
- Angiogenesis and VEGF in Cancer 1
- Oncology 5
- Inflammatory Biomarkers in Disease Prognosis 3
- Co-authors
- Edzard Schwedhelm (17 shared papers)Bernhard H. Rauch (15 shared papers)Rainer H. Böger (7 shared papers)Marcus Dörr (7 shared papers)Martin Sebastian Winkler (5 shared papers)Markus H. Gräler (2 shared papers)Günter Daum (8 shared papers)Stefan Kluge (3 shared papers)
- Journals
- European Heart Journal (2 papers)Frontiers in Pharmacology (1 paper)Transfusion (1 paper)Oncotarget (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Eileen Moritz
20 papers receiving 329 citations
Peers
Comparison fields: 5 of 66
- Molecular Biology 182
- Orthopedics and Sports Medicine 19
- Oncology 52
- Physiology 50
- Immunology 38
Countries citing papers authored by Eileen Moritz
This map shows the geographic impact of Eileen Moritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Moritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Moritz more than expected).
Fields of papers citing papers by Eileen Moritz
This network shows the impact of papers produced by Eileen Moritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Moritz. The network helps show where Eileen Moritz may publish in the future.
Co-authors
The 25 scholars most cited alongside Eileen Moritz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 97 | |
| 2 | 2017 | 66 | |
| 3 | 2017 | 26 | |
| 4 | 2019 | 25 | |
| 5 | 2020 | 20 | |
| 6 | 2021 | 18 | |
| 7 | 2022 | 11 | |
| 8 | 2018 | 11 | |
| 9 | 2017 | 10 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2017 | 8 | |
| 13 | 2019 | 7 | |
| 14 | 2021 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2021 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2024 | 1 |
About Eileen Moritz
Eileen Moritz is a scholar working on Molecular Biology, Oncology, Hematology, Physiology and Immunology, having authored 22 papers that have together received 332 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (13 papers), Platelet Disorders and Treatments (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Erythrocyte Function and Pathophysiology (3 papers), Nitric Oxide and Endothelin Effects (2 papers), COVID-19 Clinical Research Studies (2 papers), Biomedical Research and Pathophysiology (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Molecular Biology (182 citations), Orthopedics and Sports Medicine (19 citations), Oncology (52 citations), Physiology (50 citations) and Immunology (38 citations). Eileen Moritz has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Edzard Schwedhelm, Bernhard H. Rauch, Rainer H. Böger, Marcus Dörr, Martin Sebastian Winkler, Markus H. Gräler, Günter Daum, Stefan Kluge, Henry Völzke and Sarah Weske. Their work appears in journals such as European Heart Journal, Frontiers in Pharmacology, Transfusion, Oncotarget and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.